» Articles » PMID: 29560901

Late-Onset Alzheimer's Disease Polygenic Risk Profile Score Predicts Hippocampal Function

Abstract

Background: We explored the cumulative effect of several late-onset Alzheimer's disease (LOAD) risk loci using a polygenic risk profile score (RPS) approach on measures of hippocampal function, cognition, and brain morphometry.

Methods: In a sample of 231 healthy control subjects (19-55 years of age), we used an RPS to study the effect of several LOAD risk loci reported in a recent meta-analysis on hippocampal function (determined by its engagement with blood oxygen level-dependent functional magnetic resonance imaging during episodic memory) and several cognitive metrics. We also studied effects on brain morphometry in an overlapping sample of 280 subjects.

Results: There was almost no significant association of LOAD-RPS with cognitive or morphometric measures. However, there was a significant negative relationship between LOAD-RPS and hippocampal function (familywise error [small volume correction-hippocampal region of interest] p < .05). There were also similar associations for risk score based on APOE haplotype, and for a combined LOAD-RPS + APOE haplotype risk profile score (p < .05 familywise error [small volume correction-hippocampal region of interest]). Of the 29 individual single nucleotide polymorphisms used in calculating LOAD-RPS, variants in CLU, PICALM, BCL3, PVRL2, and RELB showed strong effects (p < .05 familywise error [small volume correction-hippocampal region of interest]) on hippocampal function, though none survived further correction for the number of single nucleotide polymorphisms tested.

Conclusions: There is a cumulative deleterious effect of LOAD risk genes on hippocampal function even in healthy volunteers. The effect of LOAD-RPS on hippocampal function in the relative absence of any effect on cognitive and morphometric measures is consistent with the reported temporal characteristics of LOAD biomarkers with the earlier manifestation of synaptic dysfunction before morphometric and cognitive changes.

Citing Articles

Dynamic functional network connectivity and its association with lipid metabolism in Alzheimer's disease.

Zang F, Liu X, Fan D, He C, Zhang Z, Xie C CNS Neurosci Ther. 2024; 30(9):e70029.

PMID: 39302036 PMC: 11413920. DOI: 10.1111/cns.70029.


APOE ɛ4, but not polygenic Alzheimer's disease risk, is related to longitudinal decrease in hippocampal brain activity in non-demented individuals.

Haglin S, Koch E, Schafer Hackenhaar F, Nyberg L, Kauppi K Sci Rep. 2023; 13(1):8433.

PMID: 37225733 PMC: 10209089. DOI: 10.1038/s41598-023-35316-z.


Genetically predicted telomere length and Alzheimer's disease endophenotypes: a Mendelian randomization study.

Rodriguez-Fernandez B, Vilor-Tejedor N, Arenaza-Urquijo E, Sanchez-Benavides G, Suarez-Calvet M, Operto G Alzheimers Res Ther. 2022; 14(1):167.

PMID: 36345036 PMC: 9641781. DOI: 10.1186/s13195-022-01101-9.


A review of brain imaging biomarker genomics in Alzheimer's disease: implementation and perspectives.

Li L, Yu X, Sheng C, Jiang X, Zhang Q, Han Y Transl Neurodegener. 2022; 11(1):42.

PMID: 36109823 PMC: 9476275. DOI: 10.1186/s40035-022-00315-z.


Associations of Polygenic Risk Score for Late-Onset Alzheimer's Disease With Biomarkers.

Li Q, Lv X, Jin F, Liao K, Gao L, Xu J Front Aging Neurosci. 2022; 14:849443.

PMID: 35493930 PMC: 9047857. DOI: 10.3389/fnagi.2022.849443.